drugset
drugset / Trial / NCT04882150

A Study to Determine the Safety, Drug Levels and Drug Effects of BMS-986196 and Food and Formulation Effects on Relative Absorption Healthy Participants

NCT04882150 ↗

Phase 1 Completed 102 enrolled Bristol-Myers Squibb
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to characterize the safety, tolerability, drug levels and drug effects of BMS-986196 in healthy participants. In addition, an evaluation of food and formulation effects on BMS-986196 absorption will be performed.

Timeline

Start
2021-05-27
Primary completion
2022-06-10
Completion
2022-06-10

Drugs

EvaluationDrugModalityDoseRoute
Subject BMS-986196 Unknown — —

Indications

No indication recorded.